Clinical Trial Update: AmB Dose for Cryptococcal Meningitis [Phase 3]

View source ↗

Summary

Phase 3 trial update examining AmB dose for cryptococcal meningitis; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Meningitis
• HIV Infection

Drugs mentioned

• AmB

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: Cryptococcal Meningitis, HIV Infections | Phase 3 | Status: UNKNOWN